Riluzole Oral Suspension — FDA Drug Shortage

Current — EDW Pharma, Inc. (Formerly Italfarmaco Pharma, Inc.)

The FDA lists a drug shortage record for Riluzole Oral Suspension (oral suspension) from EDW Pharma, Inc. (Formerly Italfarmaco Pharma, Inc.) with status Current. The shortage was first posted on Jan 26, 2024. Reported reason: Requirements related to complying with good manufacturing practices

Shortage details

Status
Current
Company
EDW Pharma, Inc. (Formerly Italfarmaco Pharma, Inc.)
Package NDC
70726-0303-1
Dosage Form
Oral Suspension
Presentation
Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)
Initial Posting
Jan 26, 2024

Reason

Requirements related to complying with good manufacturing practices

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.